PBT fell 73.7% as revenue growth failed to offset cost expansion

The earnings decline was severe: PBT fell 73.7% to NZ$0.5m, a more reliable operating read than NPAT because the current effective tax rate of -49.5% (compared with 3.3% in FY22) distorts the statutory bottom line through a deferred tax benefit. NPAT of NZ$0.7m fell 65.0%; the prior period also included a minor NZ$0.019m contribution from a discontinued operation, though this is immaterial to the comparison.

Operating cash flow rose 47.7% to NZ$7.1m, producing a cash conversion ratio of 197.5% of EBITDA, significantly above the prior 107.1%. This divergence from earnings reflects working-capital and balance-sheet timing rather than superior cash generation. Gross borrowings nearly doubled to NZ$30.9m, lifting net debt to NZ$28.8m and net debt to EBITDA to 8.0x from 3.3x, driven by NZ$13.9m of capital expenditure versus NZ$0.5m in FY22.

Aldwins House acquisition adds balance-sheet context, with NZ$13m acquisition price, but borrowings and gearing are the direct leverage evidence.

The 25.5% revenue increase did not translate into earnings; EBITDA compressed to NZ$3.6m from NZ$4.5m and PBT fell to NZ$0.5m. This matters because an aged-care business with rising occupancy and a broader facility footprint should, over time, generate operating leverage. The absence of that leverage in FY23 suggests the cost base—likely staffing, occupancy-related costs, and infrastructure investment—is running ahead of revenue maturity.

Leverage has moved to a level that limits financial flexibility. Net debt to EBITDA of 8.0x is elevated for an aged-care operator, particularly one still embedding acquisitions and development projects. At this leverage level, any further EBITDA softness tightens debt-service headroom and reduces the capacity to self-fund future brownfield or acquisition growth without additional external funding.

Capital expenditure dominated cash flow. Capex of NZ$13.9m represented 58.3% of revenue in FY23, against 2.6% the prior year, producing a pre-lease free cash flow of negative NZ$6.8m versus positive NZ$4.3m in FY22. This is investment-phase spending rather than routine maintenance, but until the assets generate returns at a scale that narrows the free cash flow deficit, debt servicing capacity rests almost entirely on operating cash flow.

Management commentary at the HY23 interim stage indicated an expectation of continued earnings growth in the second half, but the implied second-half NPAT of NZ$0.31m fell below the NZ$0.38m earned in the first half, suggesting that outcome was not delivered. Revenue was approximately evenly split between halves (49% first half), offering no clear acceleration signal into FY24.

The forward read depends heavily on whether the facility expansion and occupancy improvements translate into margin recovery. Until cost growth moderates relative to revenue, the revenue growth rate, while positive, does not de-risk the leverage position or validate the investment thesis.

Revenue growth is real—occupancy gains and a broader facility base are operational improvements—but the inability to convert that growth into EBITDA or PBT improvement means the reported earnings level is not a durable base; it is a transitional trough shaped by investment and integration costs. The tax benefit that lifts NPAT above PBT is a deferred tax item and does not represent cash income.

The strong operating cash flow of NZ$7.1m relative to EBITDA of NZ$3.6m reflects working-capital and resident-liability timing (consistent with aged-care ORA and accommodation deposit dynamics) rather than superior cash generation. Once capex is included, free cash flow was negative NZ$6.8m. ROE fell from 10.9% to 3.4%, consistent with the dilutive effect of a larger, not-yet-productive asset base funded by debt.

This briefing cannot assess the fair value of development assets under construction, the contracted terms of resident loans and accommodation deposits, or the sensitivity of occupancy and revenue to local demographic demand.